Medical Advocates

HAART/ART
/cART
  Musculoskeletal Adverse Events
 
General Reports  





 
 

HAART Adverse Events Main New/Newsworthy  Home Page

Last Update:   
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

                    

          Journal Papers, Abstracts, and Commentaries
 

 
Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial.
Hoy JF, Grund B, Roediger M,
J Bone Miner Res
. 2017 Jun 26.
Abstract

Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected with HIV in Early Life.
Unsal AB, Mattingly AS, Jones SE, et al
J Clin Endocrinol Metab. 2017 May
Abstract

A Single Dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-Induced Bone Loss in Treatment-naïve HIV-infected Patients: a Phase IIb Trial.
Ofotokun I, Titanji K, Lahiri CD, et al
Clin Infect Dis
. 2016 May 18.

Abstract

Protecting bone in long-term HIV positive patients receiving antiretrovirals.
McGinty T, Mallon P. 
Expert Rev Anti Infect Ther
. 2016 May 18
Abstract

Role of T-cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss.
Ofotokun I, Titanji K, Vikulina T,  et al

Nat Commun
. 2015 Sep 22;6:8282.
Abstract

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.
Overton ET, Chan ES, Brown TT,  et al
Ann Intern Med. 2015 Jun 16;

Abstract

Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment
START) trial.
Carr A, Grund B, Neuhaus J,  et al
HIV Med
. 2015 Apr;16 Suppl 1:137-46.
Abstract

Low Baseline CD4+ Count is Associated with Greater Bone Mineral Density Loss after ART Initiation.
Grant PM, Kitch D, McComsey GA, et al
Clin Infect Dis
. 2013 Aug 13.
Abstract

Impact of antiretroviral therapy on bone metabolism markers in HIV-seropositive patients.
de Menezes Barbosa EG, de Paula FJ, Machado A, et al
Bone
. 2013 Jul 24..
Abstract

Changes in bone mineral density over a two-year period in HIV-1-infected men under cART with osteopenia.
Assoumou L, Katlama C, Viard JP,  et al
AIDS
. 2013 Jun 3.
.
Abstract

Body Composition, Soluble Markers of Inflammation, and Bone Mineral Density in Antiretroviral Therapy-Naïve HIV-1 Infected Individuals.
Brown TT, Chen Y, Currier JS,  et al
J Acquir Immune Defic Syndr
. 2013 Apr 15.
Abstract

Fractures after antiretroviral initiation: An analysis of the ACTG longitudinal linked randomized trial (ALLRT) study.
Yin MT, Kendall MA, Wu X, et al
AIDS
. 2012 Aug 28..
Abstract

Markers of bone turnover are elevated in patients with antiretroviral treatment independent of the substance used.
Piso RJ, Rothen M, Rothen JP, Stahl M.
J Acquir Immune Defic Syndr
. 2011 Apr;56(4):320-4.
Abstract

 
 


HAART Adverse Events Main New/Newsworthy  Home Page

HAART/ART Musculoskeletal Adverse Events